Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer
Antag Therapeutics has appointed obesity treatment expert Philip Just Larsen as Chief…
WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination
World Health Organization and Gilead Sciences have renewed their partnership through 2030…
Century Health Raises $5M Seed Round as AI-Powered Platform Achieves 97% Accuracy in Clinical Data Abstraction
Century Health has raised an oversubscribed $5 million seed round to expand…
London Biotechnology Show 2026
London Biotechnology Show 2026 will unite global biotech leaders, pharmaceutical companies, investors,…
Atropos Health and Guidehouse Launch Point-of-Care Clinical Decision Support Solution for Life Sciences
Atropos Health and Guidehouse launched an AI-powered clinical decision support solution that…
MS Pharma Announces Strategic Growth Investment from Olayan Financing Company
MS Pharma secured a strategic minority investment from Olayan Financing Company to…
Nivey Nocher Joins The PHA Group to Lead Health Department
The PHA Group has appointed Nivey Nocher as Executive Vice President, Health,…
